αααααβααΎα109820 β’ KOSDAQ
add
Genematrix Inc
2,110.00β©
25 ααααΆ, 6:00:00 PM ααααβααα +9 · KRW · KOSDAQ · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
αα·αααΈαα»α
2,105.00β©
α
αααααααααααα
2,075.00β© - 2,145.00β©
α
ααααααα½αααααΆαα
α»αααααα
1,891.00β© - 3,835.00β©
ααΎαβαα»αβααΈααααΆα
43.03Β αααΈααΆα KRW
ααα ααα½αααΌαααααα
235.48Β ααΆαα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
KOSDAQ
ααααααΆαααΈααααΆα
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (KRW) | 2018info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 4.73Β αααΈααΆα | -8.75% |
α
αααΆαααααα·ααααα·ααΆα | 4.54Β αααΈααΆα | 26.32% |
α
αααΌααα»ααα | -3.11Β αααΈααΆα | -111.37% |
ααααΆααα
αααααα»ααα | -65.61 | -131.67% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | β | β |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | -2.46Β αααΈααΆα | -71.80% |
α’ααααΆαααααααααΆαααααα·αααααΆα | β | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (KRW) | 2018info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 15.26Β αααΈααΆα | 99.39% |
ααααααααα»α | 31.52Β αααΈααΆα | 77.64% |
ααΆαααα½ααα»αααααΌαααα»α | 20.12Β αααΈααΆα | 247.02% |
ααΌαβααααα»α | 11.40Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 16.03Β ααΆα | β |
ααααααααααΉαααααα
| 3.12 | β |
ααα
ααααααΎαααααα | -7.12% | β |
ααα
ααααααΎααΎααα»α | -7.86% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (KRW) | 2018info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | -3.11Β αααΈααΆα | -111.37% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | -2.74Β αααΈααΆα | -54.37% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -9.51Β αααΈααΆα | -650.91% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | 16.36Β αααΈααΆα | 17,898.17% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 4.11Β αααΈααΆα | 11,968.54% |
ααα αΌαααΆα
αααααΆααααααα | -1.28Β αααΈααΆα | 17.07% |
α’αααΈ
GeneMatrix Inc is a South Korean company servicing molecular diagnostics. The company is listed on KOSDAQ:109820. Its main service is to diagnose DNA mutations based on its proprietary technology of restriction fragment mass polymorphism. It is affiliated with the Seoul National University Medical Center, the largest oncology center in Korea. Wikipedia
ααΆααααααΎαα‘αΎα
2000
αααααβαααααΆα
αα»ααααα·α
69
